Mark E McGovern insider trades: Esperion Therapeutics (ESPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 6, 2016 | ESPR | ↑ Buy | 5,000 | $10.00 | $50K | Direct | Jul 7, 2016 (1d) |
| Mar 13, 2006 | KOSP | ↓ Sell | 28,750 | $49.00 | $1.4M | Direct | Mar 15, 2006 (2d) |
| Aug 10, 2005 | KOSP | ↓ Sell | 70,000 | $72.65 | $5.1M | Direct | Aug 12, 2005 (2d) |
| May 16, 2005 | KOSP | ↓ Sell | 10,000 | $53.00 | $530K | Direct | May 18, 2005 (2d) |
| May 12, 2005 | KOSP | ↓ Sell | 15,000 | $53.79 | $807K | Direct | May 16, 2005 (4d) |
| May 10, 2005 | KOSP | ↓ Sell | 10,000 | $53.84 | $538K | Direct | May 12, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ESPR insiders
Open-market trades in the last 12 months
About Mark E McGovern's insider trades
Mark E McGovern is a director at Esperion Therapeutics (ESPR). Since May 10, 2005, Mark has reported 1 open-market purchase worth $50K and 5 sales worth $8.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), option exercises (5 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ESPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.